Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 11/17/23 → 8/24/28 |
Funding
- Janssen Research and Development LLC: $18,716.00
FUZION: A Phase 3, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Guselkumab in Participants with Fistulizing, Perianal Crohn#s Disease
- Flomenhoft, Deborah (PI)